Arrested anti-abortion protester 'willing to go to jail'
Rose Docherty, 74, became the first person to be arrested and charged under a new law which creates buffer zones outside Scottish abortion clinics in February.
She has rejected a formal warning from the Crown Office - arguing that it was "unjust" - and is waiting to find out what action may now be taken against her.
Doctors at the hospital have previously told BBC Scotland News that the protests, which have been held outside the hospital for nearly 10 years, were upsetting and intimidating for patients and staff.
The Abortion Services (Safe Access Zones) Act prevents any protests or vigils from taking place within 200m (650ft) of 30 clinics around the country.
Anyone who breaks the buffer zones law could be fined up to £10,000 or an unlimited amount in more serious cases.
Woman, 74, charged under abortion protest law
Anti-abortion group starts Lent hospital protests
Ms Docherty was arrested close to the Queen Elizabeth University Hospital (QEUH) on 19 February.
She had been holding a sign that said "Coercion is a crime, here to talk, only if you want".
In her first broadcast interview since the arrest, she said she had "no reason to regret" the incident.
She told BBC's Scotcast that the arrest was an "alarming" and "surreal" experience.
Ms Docherty added: "I don't feel I was breaking the law because I feel this law is an unjust law.
"I was just standing with a sign that was stating a fact that coercion is a crime.
"I was there to speak with people only if they wanted to speak with me. I wasn't approaching anyone, I wasn't behaving in a manner that was intimidating or harassing anyone."
Dr Greg Irwin, a doctor at the QEUH, was pictured confronting a group of protestors in February 2023, saying that they "cause emotional upset to patients, but also to staff members".
He added: "One in three women will make use of abortion healthcare, so judgemental protests at the hospital gates have a real and unpleasant effect, particularly on these staff members.
"But they also affect other staff, like myself, who find it infuriating to know that there are protesters outside the hospital intimidating patients on their way in.
"It's such an unbelievably cruel and unkind thing to do, and it bothers me throughout the protest period."
The anti-abortion protests are often linked to the 40 Days for Life group - although Ms Docherty denied that she was a member of the US-based organisation.
Following her arrest, the Crown Office sent her a letter which contained a formal warning.
It said the procurator fiscal had decided against bringing Ms Docherty before a court and if she accepted the warning she would not be prosecuted.
"I said I wasn't accepting a warning because it's unjust," she said.
"I would be prepared to go to prison. I have no idea what might happen.
"I'm waiting to see what's going to develop from having written back to the procurator fiscal so it's up to them to see what their next step is."
The Abortion Services (Safe Access Zones) Act came into force last September.
It was drawn up by Scottish Green MSP Gillian Mackay, who said women seeking the procedure were subjected to "totally unacceptable abuse and obstruction" outside hospitals.
It is a criminal offence to behave in ways that could influence the decisions of women and staff to access services within the buffer zones.
Stopping women and staff from entering the clinics or otherwise causing alarm, harassment or distress is also an offence.
Gillian Mackay said patients and staff had told her that they still have to pass the protestors when attending the QEUH and "shared similar distress to what we heard during the passage of the bill".
She added: "I think it's appropriate that we take those concerns seriously and the government take a look at whether an extension is appropriate or not."
Ms Docherty denied that she had deliberately sought to be arrested for publicity, despite it taking place just days after US Vice-President JD Vance highlighted the law as an example of free speech is Europe being "in retreat".
When asked about patients or staff feeling intimidated by the protestors, Ms Docherty said: "If they say they feel that way then they must feel that way, I'm not in charge of their feelings.
"But I know that my intention is not to do that, I'm standing peacefully and quietly."
She added: "We know that women have changed their minds because something has given them pause for thought.
"If someone is being influenced, it seems to point to the fact that their mind isn't made up."
She said that moving to another location further from the hospital would make the group less visible, meaning their "offer of help" was less visible.
"People say we should go to the Scottish parliament, but that's not where the help is needed," she added.
A spokesperson for the Crown Office and Procurator Fiscal Service said: "The procurator fiscal has received a report concerning a 74-year-old in relation to an alleged incident on 19/02/2025.
"The report remains under the consideration of the procurator fiscal."
Abortion buffer zones to take effect within weeks
Abortion protests near clinics banned as buffer zones law goes live
Anti-abortion group will not break buffer zones
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
Draft of Trump's Health Blueprint Avoids Industry Crackdown
(Bloomberg) -- A draft of the Trump administration's highly anticipated blueprint on health policy takes a softer approach to regulating companies than many had feared, a relief for industry and setback for environmental activists. The US-Canadian Road Safety Gap Is Getting Wider Festivals and Parades Are Canceled Amid US Immigration Anxiety A Photographer's Pipe Dream: Capturing New York's Vast Water System To Head Off Severe Storm Surges, Nova Scotia Invests in 'Living Shorelines' Five Years After Black Lives Matter, Brussels' Colonial Statues Remain The draft report, which has been reviewed by Bloomberg News, has parts that go beyond previous announcements. They are mostly about boosting research in areas such as the risks of microplastics and how antidepressants are prescribed for children. It also refers to plans to boost fertility rates and getting whole milk into public schools. The draft was dated Aug. 11, but could still see changes before it's finalized, according to people familiar with the discussions who weren't authorized to speak publicly on the matter. In particular, the report's tone around pesticides is far less critical than Health and Human Services Secretary Robert F. Kennedy Jr. and his allies have been in the past. That raised concerns earlier this week from some of his supporters in the so-called Make America Healthy Again movement, according to the people. The policy agenda is the second installment in a two-part process to carry out an executive order that President Donald Trump signed in February. The first report detailed research about what the administration viewed as the root cause of chronic disease among children, and the second was intended to lay out policies to address those root causes. The strategy was due to be submitted to the president on Aug. 12, but hasn't been publicly released. The White House declined to confirm the draft's authenticity, but industry officials said it was largely in line with what they had been briefed on by the administration. Still, the report appeared in flux before its public release, with the debate centered on the wording of the pesticide provisions. 'Until officially released by the White House and MAHA Commission, any documents purporting to be the second MAHA Report should be disregarded as speculative literature,' said White House spokesman Kush Desai. The document aligns with the administration's strategy to create change by pressuring industries, rather than through new regulations or laws. Officials have employed the strategy with food companies, health insurers and pharmaceutical producers so far. Pesticides Approach The draft takes a lighter touch on pesticides, after a backlash from the agricultural community before the first report's release prompted an internal debate over the issue. The document calls for continually evaluating the current framework to 'ensure that chemicals and other exposures do not interact together to pose a threat to the health of our children.' It references measuring the 'cumulative exposure' to chemicals. That could rankle farmers and agriculture firms, which say that pesticides are safe to use and disputes language that suggests they could be harmful to Americans. Kennedy has been skeptical of some vaccines, and the document calls for more research on vaccine injuries. The draft has vague pronouncements such as 'ensuring scientific and medical freedom' and making sure Americans have the 'best' vaccination schedule. The agency will launch a 'MAHA education campaign' to promote the early adoption of lifestyle changes that may increase fertility rates among men and women, including through new partnerships with federally funded family planning facilities, according to the draft, which didn't provide specific examples of what would be taught. Kennedy has repeatedly raised concerns over declining sperm counts and testosterone rates, especially among teenage boys, to explain declining US birth rates. Processed Foods The draft report criticizes 'highly processed foods,' listing poor diet among the top drivers of children's chronic diseases, but didn't propose any significant new restrictions on the industry. The administration has already begun the process of defining 'ultra processed foods,' which it said will be used to develop future research funding and policies. The report refers to highly processed foods more often than ultra-processed foods and doesn't distinguish between the terms. Ultra-processed foods typically involve some industrial steps or ingredients, unlike whole foods such as fruits and vegetables. Many packaged foods are generally considered ultra-processed. The report also pointed to forthcoming revised dietary guidelines, which Trump officials have estimated will be released in the fall. Kennedy has said those guidelines will encourage people to eat 'whole foods,' and will be simple and easy to understand. The draft report previews several public health awareness campaigns it plans to launch, including a 'Real Food First' push to 'prioritize whole, minimally processed foods over packaged and highly processed alternatives.' Whole Milk Food and Drug Administration Commissioner Marty Makary has indicated the dietary guidelines will take a new approach toward saturated fat. The draft report included one hint of what could be coming, by specifically calling to remove the restrictions around serving whole milk in schools. Because the current dietary guidelines recommend limiting consumption of foods high in saturated fat to less than 10% of calories daily, schools serve only skim and 1% milk. The draft calls for increased oversight and enforcement of advertisements for direct-to-consumer drugs. The report suggests that social media influencers and telehealth companies – categories that have historically fallen into a regulatory gray area – should be subject to greater oversight when promoting drugs. Lawmakers have been pressuring the federal government to take action on the influx of advertisements from telehealth companies that offer copycat weight-loss medications. That includes allegations that Hims & Hers Health Inc. omitted safety information in advertising. --With assistance from Ilena Peng, Charles Gorrivan and Madison Muller. What Declining Cardboard Box Sales Tell Us About the US Economy Americans Are Getting Priced Out of Homeownership at Record Rates Bessent on Tariffs, Deficits and Embracing Trump's Economic Plan Twitter's Ex-CEO Is Moving Past His Elon Musk Drama and Starting an AI Company How Syrian Immigrants Are Boosting Germany's Economy ©2025 Bloomberg L.P. Sign in to access your portfolio
Yahoo
3 hours ago
- Yahoo
Merck KGaA ventures into new territory in the US
This story was originally published on PharmaVoice. To receive daily news and insights, subscribe to our free daily PharmaVoice newsletter. Merck KGaA has been making new moves to propel itself into becoming what CEO Belén Garijo described as a 'globally diversified science and technology powerhouse.' Most recently, the company closed its $3.4 billion acquisition of Pfizer spinout SpringWorks Therapeutics, which will help it stake a claim in the rare tumor space. And in general, it's all about 'doubling down' on R&D and building the company's U.S. footprint, said Miguel Fernández Alcalde, president of EMD Serono, Merck KGaA's healthcare business in the U.S. and Canada. Germany-based Merck KGaA has undergone a number of transformations throughout its deep history. In 2022, the company restructured into three distinct business units including one focused on the life sciences sector and manufacturing services. But with the contract manufacturing blitz of the COVID-19 pandemic era fading, the company is refocusing. EMD Serono relocated its U.S. headquarters to Boston's Seaport district to place itself squarely in the thick of the region's most innovative 'biotechs, startups, academia and scientists,' Fernández Alcalde said. 'I want to make sure we are bringing the U.S. [business] to the next level in terms of contributions to the whole organization." Miguel Fernández Alcalde President, EMD Serono Merck KGaA also elevated its global head of R&D and chief medical officer of its healthcare business, Dr. Danny Bar-Zohar, to healthcare CEO. 'That tells you that the company's moving along in the direction of doubling down on R&D,' Fernández Alcalde said. Fernández Alcalde's appointment to president of EMD Serono in December is also part of the company's overall quest to build its U.S. footprint and bolster R&D through external deals. 'I want to make sure we are bringing the U.S. [business] to the next level in terms of contributions to the whole organization,' he said. 'I do think we have lots of opportunities in the U.S. ecosystem and U.S. market. My job and my vision and ambition is to really untap all those things that we have ahead of us.' A pharmacist by trade, Fernández Alcalde has been with Merck KGaA since 2014, serving most recently as EMD Serono's chief operating officer. 'That gave me a lot of knowledge and understanding of the business of the company in the States and the teams, the dynamics, the culture, but also the U.S. [healthcare] ecosystem,' he said. Driving dealmaking Central to Fernández Alcalde's role is supplementing the company's current pipeline through external innovation investments, including more strategic in-licensing and co-development opportunities. The SpringWorks acquisition put the company on track to generate at least 50% of its future launch assets from external companies, compared to roughly 10%-15% just 18 months ago. 'It's easily a fivefold increase in our ambition from external innovation,' Fernández Alcalde said. In terms of what kinds of deals they're targeting, Fernández Alcalde said several factors are at play. 'We are not looking [for] the $40 billion type of acquisition,' he said. Nor will they chase first-in-class potential blockbusters with never-explored mechanisms of action. Instead, they'll target smaller deals with the 'right risk balance' for their pipeline. He pointed to the SpringWorks acquisition as an example, which not only adds two FDA-approved drugs to its portfolio, but also a 'runway of three to five years of nice growth' in the form of several clinical-phase pipeline candidates. 'These areas where we have deep, good science [and a] validated proof of concept or an about-to-be-validated proof of concept where the mechanism of action is already validated, is something we are interested in,' he said. The company will take a similar approach when it comes to therapeutic areas by branching out within reason. 'We are not sticking to the [therapeutic areas] we have today, but we are not going to go wild, either,' he said. Rather, they'll look for specialties that are 'adjacent' and 'logical' in terms of what they've been historically known for, such as oncology and neurology/immunology. Again, he pointed to the SpringWorks acquisition as an example and noted that some might ask what track record EMD Serono or Merck KGaA has in rare tumors. 'The answer is zero. But we do know how to commercialize,' he said. Plus, 'it's in an adjacent area of oncology.' Fernández Alcalde is also thinking globally, intending to follow good science wherever it leads and consider deals from around the world. 'We couldn't care less about where that science is coming from, whether it's China, my home country Spain, the U.S. or South Africa,' he said. 'If we think that science will help patients … we will definitely think about it.' Recommended Reading Let's make a deal? Big Pharma execs express varying views on their M&A future
Boston Globe
4 hours ago
- Boston Globe
In 2023, Mass. hospitals pushed executive pay to new heights
That total reflected base salary, bonus pay, retirement benefits, and more. It was a 40.1 percent increase from the prior year, and included roughly $4.3 million in bonus and incentive pay. The amount is the highest total compensation reported by a Massachusetts hospital CEO in at least the last decade. In a statement, MGB Board Chairman Scott Sperling stood by Klibanski's compensation package, which he said was based on industry benchmarks with input from a consultant. Advertisement 'The challenges facing our industry are many, and the competition for top talent is unprecedented. It is imperative that we actively and robustly recruit and retain at every level to ensure we can expertly care for patients and communities for years to come,' Sperling said. 'Our objective, on average, is to base compensation for our senior executives at the 50th percentile of the current market, with performance driving any adjustments,' he said. Advertisement Previously, the health system has pointed to the leaders at other national health systems than her Massachusetts colleagues. Indeed, her 2023 salary ranked below some, including CEO of New York-based Northwell Health ($9 million) and Arizona-based Banner Health ($14 million). However Klibanski eclipsed others, including the CEOs at Cleveland Clinic ($7 million), and Mayo Clinic ($4.3 million). While the most recent compensation report lags by two years, Sperling pointed to how Klibanski had handled recent challenges as an example of what he said was her 'clear-eyed leadership,' including disruptive federal actions that have threatened research and an inpatient capacity crises. Dr. Anne Klibanski, with then-Governor Charlie Baker, pictured speaking at a coronavirus briefing in 2020. Sam Doran/Pool 'The Board of Directors fully supports Dr. Klibanski's compensation package ... which reflects her achievements and stewardship of an organization of this size and complexity,' Sperling said. Klibanski had plenty of company in the ranks of well-paid Massachusetts hospital executives in 2023. Dr. Kevin Tabb, who heads the state's second largest health system, Beth Israel Lahey Health, also reported a sizable increase, with his $5.4 million in total compensation representing a 93 percent increase from the prior year. The increases were a return to compensation Tabb reported in 2021, and were largely thanks to increases in bonus and incentive comp, as well as retirement and other deferred compensation. Dr. Eric Dickson, chief executive of UMass Memorial Health, reported a nearly 26 percent increase in total comp, to $3.9 million. The hospital said it changed its retirement plan in 2023, prompting an early payout of some benefits. That shift subsequently boosted the incentive compensation of several executives, including Dickson. Advertisement Similarly, Dr. Michael Gustafson, who left as president of UMass's flagship hospital, UMass Memorial Medical Center, in July 2023, reported a 60 percent increase in total comp to $2.8 million. Michael Dandorph, who helms Tufts Medicine, also reported a double digit increase in total comp. His $2.1 million total compensation was 32 percent higher than the previous year. Dr. Alastair Bell, CEO of Boston Medical Center Health System since June 2023 and its president since November 2022, saw his total comp increase by 34 percent to $1.9 million. Large jumps weren't universal. Other executives saw smaller changes including Dr. Kevin Churchwell ($3.2 million, down 5 percent) at Boston Children's Hospital, Dr. Mark Keroack ($2.8 million, a 4.8 percent increase) at Baystate Health where he served until 2024, and Dr. Laurie Glimcher ($2.5 million, up 5 percent) at Dana-Farber Cancer Institute which she led until 2024. Dr. Kevin Churchwell, CEO of Boston Children's Hospital, saw his compensation go down 5 percent from 2022 to 2023. Erin Clark/Globe Staff The data tracks with a study by the Harvard School of Public Health, which showed that executives overseeing large teaching hospitals nationally were the highest compensated. The study, However, there was no association between compensation and the degree of community benefit a hospital provided, nor was higher compensation associated with better patient mortality rates or readmission rates, according to the study. The Massachusetts Nurses Association lambasted executives for the pay, particularly as they said the quality of care at hospitals across the state has suffered. 'At a time when nearly 80% of Massachusetts nurses say hospital care has gotten worse in the last two years, it is deeply troubling that hospital CEOs are taking home enormous compensation packages while continuing to fail to ensure safe conditions for patients and direct care providers,' the nurses union said in a statement. Advertisement 'The very same executives receiving millions of dollars per year are making decisions not to invest in bedside care or listen to caregivers,' it said. The salaries reflect a time when hospitals were just beginning to climb out of the effects from the pandemic. Volume and revenue had begun to rebound in the year that for many hospitals ended September 2023, with Often, hospital executive compensation has been tied to a system's size and comparisons to others in the market, said Susan Malanowski, managing director of compensation consultant the Wilson Group. There are pressures on boards to hire competent executives, and the pool of applicants is smaller than it has been in the past. 'To be competitive, it is what it is,' Malanowski said. 'There is not really a big supply of competent CEOs or c-suite (executives).' While the most recent compensation data is for 2023, hospitals will be harder pressed to support large pay packages in 2025 and onward, Malanowski predicted. Uncertainty at the federal level will mean non-profit institutions will have to be more circumspect about where they set base salaries, and compensation increases are projected to be smaller. Advertisement Jessica Bartlett can be reached at
